Bellevue Group AG trimmed its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 1.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 237,286 shares of the biotechnology company’s stock after selling 4,466 shares during the […]